146 related articles for article (PubMed ID: 23638244)
1. Characterizing at-Risk Voxels by Using Perfusion Magnetic Resonance Imaging for Cervical Cancer during Radiotherapy.
Huang Z; Mayr NA; Lo SS; Grecula JC; Wang JZ; Jia G; Yuh WT
J Cancer Sci Ther; 2012 Sep; 4(9):254-259. PubMed ID: 23638244
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effects of hemoglobin and tumor perfusion on tumor control and survival in cervical cancer.
Mayr NA; Wang JZ; Zhang D; Montebello JF; Grecula JC; Lo SS; Fowler JM; Yuh WT
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1513-21. PubMed ID: 19286329
[TBL] [Abstract][Full Text] [Related]
3. Validation of optimal DCE-MRI perfusion threshold to classify at-risk tumor imaging voxels in heterogeneous cervical cancer for outcome prediction.
Huang Z; Yuh KA; Lo SS; Grecula JC; Sammet S; Sammet CL; Jia G; Knopp MV; Wu Q; Beauchamp NJ; Yuh WT; Wang R; Mayr NA
Magn Reson Imaging; 2014 Dec; 32(10):1198-205. PubMed ID: 25179141
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal changes in tumor perfusion pattern during the radiation therapy course and its clinical impact in cervical cancer.
Mayr NA; Wang JZ; Zhang D; Grecula JC; Lo SS; Jaroura D; Montebello J; Zhang H; Li K; Lu L; Huang Z; Fowler JM; Wu DH; Knopp MV; Yuh WT
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):502-8. PubMed ID: 19775824
[TBL] [Abstract][Full Text] [Related]
5. Characterizing tumor heterogeneity with functional imaging and quantifying high-risk tumor volume for early prediction of treatment outcome: cervical cancer as a model.
Mayr NA; Huang Z; Wang JZ; Lo SS; Fan JM; Grecula JC; Sammet S; Sammet CL; Jia G; Zhang J; Knopp MV; Yuh WT
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):972-9. PubMed ID: 22208967
[TBL] [Abstract][Full Text] [Related]
6. Voxelwise comparison of perfusion parameters estimated using dynamic contrast enhanced (DCE) computed tomography and DCE-magnetic resonance imaging in locally advanced cervical cancer.
Kallehauge J; Nielsen T; Haack S; Peters DA; Mohamed S; Fokdal L; Lindegaard JC; Hansen DC; Rasmussen F; Tanderup K; Pedersen EM
Acta Oncol; 2013 Oct; 52(7):1360-8. PubMed ID: 24003852
[TBL] [Abstract][Full Text] [Related]
7. Predicting control of primary tumor and survival by DCE MRI during early therapy in cervical cancer.
Yuh WT; Mayr NA; Jarjoura D; Wu D; Grecula JC; Lo SS; Edwards SM; Magnotta VA; Sammet S; Zhang H; Montebello JF; Fowler J; Knopp MV; Wang JZ
Invest Radiol; 2009 Jun; 44(6):343-50. PubMed ID: 19661844
[TBL] [Abstract][Full Text] [Related]
8. Tumor radiomic heterogeneity: Multiparametric functional imaging to characterize variability and predict response following cervical cancer radiation therapy.
Bowen SR; Yuh WTC; Hippe DS; Wu W; Partridge SC; Elias S; Jia G; Huang Z; Sandison GA; Nelson D; Knopp MV; Lo SS; Kinahan PE; Mayr NA
J Magn Reson Imaging; 2018 May; 47(5):1388-1396. PubMed ID: 29044908
[TBL] [Abstract][Full Text] [Related]
9. Utilization of functional MRI in the diagnosis and management of cervical cancer.
Matani H; Patel AK; Horne ZD; Beriwal S
Front Oncol; 2022; 12():1030967. PubMed ID: 36439416
[TBL] [Abstract][Full Text] [Related]
10. Ultra-early predictive assay for treatment failure using functional magnetic resonance imaging and clinical prognostic parameters in cervical cancer.
Mayr NA; Yuh WT; Jajoura D; Wang JZ; Lo SS; Montebello JF; Porter K; Zhang D; McMeekin DS; Buatti JM
Cancer; 2010 Feb; 116(4):903-12. PubMed ID: 20052727
[TBL] [Abstract][Full Text] [Related]
11. Functional Tumor Volume by Fast Dynamic Contrast-Enhanced MRI for Predicting Neoadjuvant Systemic Therapy Response in Triple-Negative Breast Cancer.
Musall BC; Abdelhafez AH; Adrada BE; Candelaria RP; Mohamed RMM; Boge M; Le-Petross H; Arribas E; Lane DL; Spak DA; Leung JWT; Hwang KP; Son JB; Elshafeey NA; Mahmoud HS; Wei P; Sun J; Zhang S; White JB; Ravenberg EE; Litton JK; Damodaran S; Thompson AM; Moulder SL; Yang WT; Pagel MD; Rauch GM; Ma J
J Magn Reson Imaging; 2021 Jul; 54(1):251-260. PubMed ID: 33586845
[TBL] [Abstract][Full Text] [Related]
12. Reproducibility of the aortic input function (AIF) derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the kidneys in a volunteer study.
Mendichovszky IA; Cutajar M; Gordon I
Eur J Radiol; 2009 Sep; 71(3):576-81. PubMed ID: 19004588
[TBL] [Abstract][Full Text] [Related]
13. Radiation-induced parotid changes in oropharyngeal cancer patients: the role of early functional imaging and patient-/treatment-related factors.
Marzi S; Farneti A; Vidiri A; Di Giuliano F; Marucci L; Spasiano F; Terrenato I; Sanguineti G
Radiat Oncol; 2018 Oct; 13(1):189. PubMed ID: 30285893
[TBL] [Abstract][Full Text] [Related]
14. Dynamic contrast-enhanced MRI of nasopharyngeal carcinoma: correlation of quantitative dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) parameters with hypoxia-inducible factor 1α expression and tumor grade/stage.
Liu L; Hu L; Zeng Q; Peng D; Chen Z; Huang C; Liu Z; Wen Q; Zou F; Yan L
Ann Palliat Med; 2021 Feb; 10(2):2238-2253. PubMed ID: 33725777
[TBL] [Abstract][Full Text] [Related]
15. Parotid perfusion in nasopharyngeal carcinoma patients in early-to-intermediate stage after low-dose intensity-modulated radiotherapy: evaluated by fat-saturated dynamic contrast-enhanced magnetic resonance imaging.
Cheng CC; Chiu SC; Jen YM; Chang HC; Chung HW; Liu YJ; Chiu HC; Chen CY; Huang GS; Juan CJ
Magn Reson Imaging; 2013 Oct; 31(8):1278-84. PubMed ID: 23664679
[TBL] [Abstract][Full Text] [Related]
16. Cluster analysis of dynamic contrast enhanced MRI reveals tumor subregions related to locoregional relapse for cervical cancer patients.
Torheim T; Groendahl AR; Andersen EK; Lyng H; Malinen E; Kvaal K; Futsaether CM
Acta Oncol; 2016 Nov; 55(11):1294-1298. PubMed ID: 27564398
[TBL] [Abstract][Full Text] [Related]
17. Modeling Dynamic Contrast-Enhanced MRI Data with a Constrained Local AIF.
Duan C; Kallehauge JF; Pérez-Torres CJ; Bretthorst GL; Beeman SC; Tanderup K; Ackerman JJH; Garbow JR
Mol Imaging Biol; 2018 Feb; 20(1):150-159. PubMed ID: 28536804
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Voxel-Wise Tumor Perfusion Changes Measured With Dynamic Contrast-Enhanced (DCE) MRI and Volumetric DCE CT in Patients With Metastatic Brain Cancer Treated with Radiosurgery.
Coolens C; Driscoll B; Foltz W; Pellow C; Menard C; Chung C
Tomography; 2016 Dec; 2(4):325-333. PubMed ID: 30042966
[TBL] [Abstract][Full Text] [Related]
19. Detection of local recurrent prostate cancer after radical prostatectomy in terms of salvage radiotherapy using dynamic contrast enhanced-MRI without endorectal coil.
Rischke HC; Schäfer AO; Nestle U; Volegova-Neher N; Henne K; Benz MR; Schultze-Seemann W; Langer M; Grosu AL
Radiat Oncol; 2012 Oct; 7():185. PubMed ID: 23114282
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the lactate-to-N-acetyl-aspartate ratio defined with magnetic resonance spectroscopic imaging before radiation therapy as a new predictive marker of the site of relapse in patients with glioblastoma multiforme.
Deviers A; Ken S; Filleron T; Rowland B; Laruelo A; Catalaa I; Lubrano V; Celsis P; Berry I; Mogicato G; Cohen-Jonathan Moyal E; Laprie A
Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):385-93. PubMed ID: 25104068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
